Aprea Therapeutics, Inc. financial data

Symbol
APRE on Nasdaq
Location
3805 Old Easton Road, Doylestown, PA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 591 % -25.5%
Debt-to-equity 15.1 % -45.9%
Return On Equity -88.1 % -52.3%
Return On Assets -68.8 % -43.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.31M shares +16.1%
Common Stock, Shares, Outstanding 5.98M shares +10%
Entity Public Float 10M USD 0%
Common Stock, Value, Issued 5.98K USD +10%
Weighted Average Number of Shares Outstanding, Basic 6.37M shares +7.29%
Weighted Average Number of Shares Outstanding, Diluted 6.37M shares +7.29%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 5.91M USD -15.9%
Operating Income (Loss) -13.8M USD +6.44%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -13M USD +3.47%
Earnings Per Share, Basic -2 USD/shares +23.5%
Earnings Per Share, Diluted -2 USD/shares +19.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.7M USD -47.7%
Assets, Current 13.9M USD -47.3%
Property, Plant and Equipment, Net 65.2K USD -25%
Other Assets, Noncurrent 271K USD -3.73%
Assets 14.3M USD -46.7%
Accounts Payable, Current 641K USD -44.4%
Employee-related Liabilities, Current 589K USD -12.6%
Liabilities, Current 2.68M USD -26.3%
Liabilities 3.95M USD -48.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -10.6M USD -0.23%
Retained Earnings (Accumulated Deficit) -331M USD -4.1%
Stockholders' Equity Attributable to Parent 10.9M USD -50.3%
Liabilities and Equity 14.3M USD -46.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.63M USD +7.74%
Net Cash Provided by (Used in) Financing Activities 55.8K USD -99.6%
Net Cash Provided by (Used in) Investing Activities -7.98K USD
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 5.98M shares +10%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 13.8M USD -47.7%
Deferred Tax Assets, Valuation Allowance 50.2M USD +1.46%
Deferred Tax Assets, Gross 50.2M USD +1.46%
Payments to Acquire Property, Plant, and Equipment 7.98K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -13.1M USD +3.06%
Property, Plant and Equipment, Gross 154K USD +11.2%
Deferred Tax Assets, Operating Loss Carryforwards 41.1M USD -1.74%
Preferred Stock, Shares Authorized 40M shares 0%
Additional Paid in Capital 353M USD +0.58%
Depreciation, Depletion and Amortization 5.43K USD -11.8%
Share-based Payment Arrangement, Expense 100K USD -32.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%